Effect of (R)-(-)-Linalool on endothelial damage: Sex differences.

(R)-(−)-Linalool Endothelial cells Endothelial damage Lipopolysaccharide Sex differences

Journal

Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999

Informations de publication

Date de publication:
Dec 2024
Historique:
received: 28 08 2024
revised: 23 09 2024
accepted: 10 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Oxidative stress and inflammation are responsible for endothelial damage displaying many sex differences. Lipopolysaccharide (LPS) is a pathogenic stimulus that can trigger inflammation, contributing to endothelial dysfunction. Given the scientific evidence on the effectiveness of herbal extracts in managing endothelial dysfunction, we considered the (R)-(-)-Linalool (LIN), an aromatic monoterpene alcohol, as a bioactive phytochemical compound that could prevent and improve endothelial injury. In this study, we evaluated the effect of the LIN on LPS-induced damage in female and male human umbilical vein endothelial cells (FHUVECs and MHUVECs), measuring cell viability, cytokines release (IL-6 and TNF-α), malondialdehyde (MDA), and nitrites. LPS significantly reduced viability both in MHUVECs and FHUVECs. Moreover, LPS increased the IL-6, TNF-α, and MDA level only in FHUVECs if compared to basal value; despite that, LPS reduced nitrites only in MHUVECs. LIN alone did not affect the parameters measured except for an increase in nitrites in FHUVECs. Nevertheless, LIN reduced damage and restored endothelium viability reduced by LPS without a clear sex difference. Under LPS, LIN inhibited IL-6 release and reduced MDA levels only in FHUVECs. The present data confirm the existence of sex differences in the behavior of HUVECs under LPS conditions. The administration of LIN seems to have a more evident effect on FHUVECs after damage induced by LPS. These LIN effects are important to conduct further well-designed studies on the sex-specific use of this compound on vascular endothelial injury.

Identifiants

pubmed: 39483177
doi: 10.1016/j.bbrep.2024.101846
pii: S2405-5808(24)00210-3
pmc: PMC11525626
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101846

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors have no conflict(s) of interest to declare.

Auteurs

Laura Doro (L)

Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.

Alessandra T Peana (AT)

Department of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.

Rossana Migheli (R)

Department of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.

Giampiero Capobianco (G)

Department of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.
Gynecologic and Obstetric Clinic, AOU, Viale San Pietro 12, 07100, Sassari, Italy.

Massimo Criscione (M)

Department of Medicine, Surgery and Pharmacy, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.

Andrea Montella (A)

Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.

Ilaria Campesi (I)

Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy.

Classifications MeSH